

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 9.48576883 |
| 2 | epoxygenase P450 pathway (GO:0019373) | 9.33063978 |
| 3 | omega-hydroxylase P450 pathway (GO:0097267) | 9.19242166 |
| 4 | drug catabolic process (GO:0042737) | 9.05399943 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 7.48482086 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.48482086 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 7.14356971 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.14356971 |
| 9 | aromatic amino acid family catabolic process (GO:0009074) | 6.99640011 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 6.60983009 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 6.60983009 |
| 12 | tryptophan catabolic process (GO:0006569) | 6.60983009 |
| 13 | bile acid biosynthetic process (GO:0006699) | 6.43202498 |
| 14 | kynurenine metabolic process (GO:0070189) | 6.39130349 |
| 15 | complement activation, alternative pathway (GO:0006957) | 6.34532942 |
| 16 | drug metabolic process (GO:0017144) | 6.32966760 |
| 17 | tryptophan metabolic process (GO:0006568) | 6.17638606 |
| 18 | glyoxylate metabolic process (GO:0046487) | 5.96851264 |
| 19 | * regulation of protein activation cascade (GO:2000257) | 5.93216495 |
| 20 | ethanol metabolic process (GO:0006067) | 5.87283693 |
| 21 | oxidative demethylation (GO:0070989) | 5.81519990 |
| 22 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.75908842 |
| 23 | urea metabolic process (GO:0019627) | 5.73545320 |
| 24 | urea cycle (GO:0000050) | 5.73545320 |
| 25 | * regulation of complement activation (GO:0030449) | 5.61743786 |
| 26 | negative regulation of fibrinolysis (GO:0051918) | 5.59387047 |
| 27 | alpha-linolenic acid metabolic process (GO:0036109) | 5.48247949 |
| 28 | protein carboxylation (GO:0018214) | 5.47414547 |
| 29 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.47414547 |
| 30 | regulation of fibrinolysis (GO:0051917) | 5.47233569 |
| 31 | cysteine metabolic process (GO:0006534) | 5.31223837 |
| 32 | sulfur amino acid catabolic process (GO:0000098) | 5.29121529 |
| 33 | nitrogen cycle metabolic process (GO:0071941) | 5.27273808 |
| 34 | bile acid metabolic process (GO:0008206) | 5.26234275 |
| 35 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.21109244 |
| 36 | high-density lipoprotein particle remodeling (GO:0034375) | 5.08905932 |
| 37 | aromatic amino acid family metabolic process (GO:0009072) | 5.06299916 |
| 38 | regulation of plasminogen activation (GO:0010755) | 4.99899749 |
| 39 | serine family amino acid catabolic process (GO:0009071) | 4.98384799 |
| 40 | phenylpropanoid metabolic process (GO:0009698) | 4.85890552 |
| 41 | * regulation of humoral immune response (GO:0002920) | 4.85087726 |
| 42 | regulation of triglyceride catabolic process (GO:0010896) | 4.82961164 |
| 43 | coenzyme catabolic process (GO:0009109) | 4.77764016 |
| 44 | homocysteine metabolic process (GO:0050667) | 4.76523414 |
| 45 | lysine catabolic process (GO:0006554) | 4.70721140 |
| 46 | lysine metabolic process (GO:0006553) | 4.70721140 |
| 47 | tyrosine metabolic process (GO:0006570) | 4.67940628 |
| 48 | indolalkylamine metabolic process (GO:0006586) | 4.66410144 |
| 49 | alpha-amino acid catabolic process (GO:1901606) | 4.60877555 |
| 50 | negative regulation of blood coagulation (GO:0030195) | 4.57974940 |
| 51 | negative regulation of hemostasis (GO:1900047) | 4.57974940 |
| 52 | triglyceride homeostasis (GO:0070328) | 4.56622344 |
| 53 | acylglycerol homeostasis (GO:0055090) | 4.56622344 |
| 54 | amine catabolic process (GO:0009310) | 4.56406638 |
| 55 | cellular biogenic amine catabolic process (GO:0042402) | 4.56406638 |
| 56 | reverse cholesterol transport (GO:0043691) | 4.51741972 |
| 57 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.51536477 |
| 58 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.51536477 |
| 59 | bile acid and bile salt transport (GO:0015721) | 4.44857827 |
| 60 | glycine metabolic process (GO:0006544) | 4.43757718 |
| 61 | amino-acid betaine metabolic process (GO:0006577) | 4.43718986 |
| 62 | S-adenosylmethionine metabolic process (GO:0046500) | 4.41977760 |
| 63 | plasma lipoprotein particle remodeling (GO:0034369) | 4.40672576 |
| 64 | protein-lipid complex remodeling (GO:0034368) | 4.40672576 |
| 65 | macromolecular complex remodeling (GO:0034367) | 4.40672576 |
| 66 | ethanol oxidation (GO:0006069) | 4.36739782 |
| 67 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.35700117 |
| 68 | cellular glucuronidation (GO:0052695) | 4.33638558 |
| 69 | * cytolysis (GO:0019835) | 4.32427909 |
| 70 | imidazole-containing compound metabolic process (GO:0052803) | 4.31043378 |
| 71 | regulation of cholesterol esterification (GO:0010872) | 4.28627810 |
| 72 | cellular amino acid catabolic process (GO:0009063) | 4.24464080 |
| 73 | phospholipid efflux (GO:0033700) | 4.19826990 |
| 74 | serine family amino acid metabolic process (GO:0009069) | 4.19645114 |
| 75 | * complement activation, classical pathway (GO:0006958) | 4.18343198 |
| 76 | glutamate metabolic process (GO:0006536) | 4.17815148 |
| 77 | negative regulation of coagulation (GO:0050819) | 4.17506624 |
| 78 | negative regulation of wound healing (GO:0061045) | 4.15617634 |
| 79 | benzene-containing compound metabolic process (GO:0042537) | 4.14364511 |
| 80 | cellular ketone body metabolic process (GO:0046950) | 4.14216807 |
| 81 | negative regulation of complement activation (GO:0045916) | 4.13253154 |
| 82 | plasma lipoprotein particle clearance (GO:0034381) | 4.10522764 |
| 83 | * complement activation (GO:0006956) | 4.09317819 |
| 84 | negative regulation of sterol transport (GO:0032372) | 4.07695430 |
| 85 | negative regulation of cholesterol transport (GO:0032375) | 4.07695430 |
| 86 | fibrinolysis (GO:0042730) | 4.06111193 |
| 87 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.03177786 |
| 88 | cellular modified amino acid catabolic process (GO:0042219) | 4.01342483 |
| 89 | hormone catabolic process (GO:0042447) | 4.00164502 |
| 90 | cholesterol efflux (GO:0033344) | 3.96159555 |
| 91 | * protein activation cascade (GO:0072376) | 3.95004078 |
| 92 | flavonoid metabolic process (GO:0009812) | 3.94782508 |
| 93 | arginine metabolic process (GO:0006525) | 3.93673352 |
| 94 | aldehyde catabolic process (GO:0046185) | 3.92431237 |
| 95 | acetyl-CoA metabolic process (GO:0006084) | 3.91776034 |
| 96 | serine family amino acid biosynthetic process (GO:0009070) | 3.91276813 |
| 97 | cofactor catabolic process (GO:0051187) | 3.89711735 |
| 98 | blood coagulation, intrinsic pathway (GO:0007597) | 3.86787130 |
| 99 | uronic acid metabolic process (GO:0006063) | 3.86238705 |
| 100 | glucuronate metabolic process (GO:0019585) | 3.86238705 |
| 101 | alkaloid metabolic process (GO:0009820) | 3.84995526 |
| 102 | positive regulation of blood coagulation (GO:0030194) | 3.83105950 |
| 103 | positive regulation of hemostasis (GO:1900048) | 3.83105950 |
| 104 | response to mercury ion (GO:0046689) | 3.80869267 |
| 105 | regulation of bile acid biosynthetic process (GO:0070857) | 3.80416359 |
| 106 | phospholipid homeostasis (GO:0055091) | 3.74927475 |
| 107 | regulation of cholesterol homeostasis (GO:2000188) | 3.74234877 |
| 108 | regulation of apoptotic cell clearance (GO:2000425) | 3.71440798 |
| 109 | acute inflammatory response (GO:0002526) | 3.70976736 |
| 110 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.69906603 |
| 111 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.69906603 |
| 112 | organic acid catabolic process (GO:0016054) | 3.69131083 |
| 113 | carboxylic acid catabolic process (GO:0046395) | 3.69131083 |
| 114 | cholesterol homeostasis (GO:0042632) | 3.64742837 |
| 115 | negative regulation of protein activation cascade (GO:2000258) | 3.64431548 |
| 116 | plasma lipoprotein particle assembly (GO:0034377) | 3.63717184 |
| 117 | low-density lipoprotein particle remodeling (GO:0034374) | 3.61102279 |
| 118 | sterol homeostasis (GO:0055092) | 3.58810317 |
| 119 | ketone body metabolic process (GO:1902224) | 3.58079684 |
| 120 | negative regulation of lipase activity (GO:0060192) | 3.57948660 |
| 121 | NAD biosynthetic process (GO:0009435) | 3.57515882 |
| 122 | positive regulation of lipid catabolic process (GO:0050996) | 3.55743868 |
| 123 | negative regulation of humoral immune response (GO:0002921) | 3.55509547 |
| 124 | xenobiotic metabolic process (GO:0006805) | 3.55372668 |
| 125 | response to nitrosative stress (GO:0051409) | 3.54085977 |
| 126 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.53953731 |
| 127 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.53695823 |
| 128 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.53695823 |
| 129 | positive regulation of coagulation (GO:0050820) | 3.51201688 |
| 130 | primary alcohol catabolic process (GO:0034310) | 3.50882884 |
| 131 | opsonization (GO:0008228) | 3.50193357 |
| 132 | intestinal cholesterol absorption (GO:0030299) | 3.49404418 |
| 133 | acute-phase response (GO:0006953) | 3.49297684 |
| 134 | oxaloacetate metabolic process (GO:0006107) | 3.38526826 |
| 135 | * regulation of acute inflammatory response (GO:0002673) | 3.29820912 |
| 136 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.29323959 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.21083680 |
| 2 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.14811880 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.10597245 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.39954948 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.24716872 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.92130153 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.88188454 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.18106978 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.86588966 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.13105000 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.01436430 |
| 12 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.01328344 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.8600733 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.91972987 |
| 15 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.84442926 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 1.71250399 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.62571039 |
| 18 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62153113 |
| 19 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.57963899 |
| 20 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.38432438 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.33912039 |
| 22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.29690465 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.22159169 |
| 24 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.19969620 |
| 25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.18985483 |
| 26 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.15362681 |
| 27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.04194994 |
| 28 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.03807092 |
| 29 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.01802858 |
| 30 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.00384407 |
| 31 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.98717321 |
| 32 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.96731819 |
| 33 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.96494894 |
| 34 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95280212 |
| 35 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.95136525 |
| 36 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.94703302 |
| 37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.90780237 |
| 38 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.87286539 |
| 39 | NFYA_21822215_ChIP-Seq_K562_Human | 0.87098434 |
| 40 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.85873759 |
| 41 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.84586431 |
| 42 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.84533413 |
| 43 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.82934913 |
| 44 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.82337869 |
| 45 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.80259709 |
| 46 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80236155 |
| 47 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.79431634 |
| 48 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.78757644 |
| 49 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.77877228 |
| 50 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.77484480 |
| 51 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.77161254 |
| 52 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.75558851 |
| 53 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.74345332 |
| 54 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.74011682 |
| 55 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.73946047 |
| 56 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.73501848 |
| 57 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.72953591 |
| 58 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.72784159 |
| 59 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.72754074 |
| 60 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.72280804 |
| 61 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.70972177 |
| 62 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.70454211 |
| 63 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.70410350 |
| 64 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.69952417 |
| 65 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.69782481 |
| 66 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.69782481 |
| 67 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.69752281 |
| 68 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.69752281 |
| 69 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.68970860 |
| 70 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.67979247 |
| 71 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.67044968 |
| 72 | NFYB_21822215_ChIP-Seq_K562_Human | 0.65542612 |
| 73 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.64468807 |
| 74 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.63188951 |
| 75 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.62718488 |
| 76 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62404716 |
| 77 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.61795745 |
| 78 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.61324532 |
| 79 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.60586928 |
| 80 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.59790654 |
| 81 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.59323735 |
| 82 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.59206458 |
| 83 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.58227202 |
| 84 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.58218054 |
| 85 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.58214829 |
| 86 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.57437076 |
| 87 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.56992964 |
| 88 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.56396167 |
| 89 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56370127 |
| 90 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.55680258 |
| 91 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.55455432 |
| 92 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.55409860 |
| 93 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.55060335 |
| 94 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.54809215 |
| 95 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.54680378 |
| 96 | AR_20517297_ChIP-Seq_VCAP_Human | 0.53686860 |
| 97 | TBL1_22424771_ChIP-Seq_293T_Human | 0.53459999 |
| 98 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.53449086 |
| 99 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.53267987 |
| 100 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.53256967 |
| 101 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.52906960 |
| 102 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.52790521 |
| 103 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.51952635 |
| 104 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.51438652 |
| 105 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.49913011 |
| 106 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.49537450 |
| 107 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.49241433 |
| 108 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48757578 |
| 109 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.48605397 |
| 110 | * ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.46516102 |
| 111 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.46015260 |
| 112 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.45593583 |
| 113 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.44984756 |
| 114 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.44242252 |
| 115 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.44148219 |
| 116 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.42808303 |
| 117 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.42733631 |
| 118 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.42475430 |
| 119 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42132147 |
| 120 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.41652596 |
| 121 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40069519 |
| 122 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.39863994 |
| 123 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.39488403 |
| 124 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.39311566 |
| 125 | GATA2_19941826_ChIP-Seq_K562_Human | 0.38977726 |
| 126 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.38927114 |
| 127 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.38666969 |
| 128 | GATA1_19941826_ChIP-Seq_K562_Human | 0.38447237 |
| 129 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.37432779 |
| 130 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.37389770 |
| 131 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.37371051 |
| 132 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.37049196 |
| 133 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.36770492 |
| 134 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.35922269 |
| 135 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.34918075 |
| 136 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.34346594 |
| 137 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.33982697 |
| 138 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.33899634 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.18704891 |
| 2 | MP0005360_urolithiasis | 7.53684187 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.55558880 |
| 4 | MP0005365_abnormal_bile_salt | 6.17917332 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.70476905 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.35591085 |
| 7 | MP0003252_abnormal_bile_duct | 4.02584351 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.56799248 |
| 9 | MP0009840_abnormal_foam_cell | 3.04496154 |
| 10 | MP0005083_abnormal_biliary_tract | 3.00588168 |
| 11 | MP0005332_abnormal_amino_acid | 2.65048323 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.63922357 |
| 13 | MP0003195_calcinosis | 2.61416231 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.48580223 |
| 15 | MP0000609_abnormal_liver_physiology | 2.16727265 |
| 16 | MP0002118_abnormal_lipid_homeostasis | 2.10908502 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.04402065 |
| 18 | MP0003868_abnormal_feces_composition | 2.01497246 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 1.98176765 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.84041329 |
| 21 | MP0001764_abnormal_homeostasis | 1.65514830 |
| 22 | MP0009697_abnormal_copulation | 1.55003752 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.53644374 |
| 24 | MP0005647_abnormal_sex_gland | 1.32358802 |
| 25 | MP0003011_delayed_dark_adaptation | 1.30258989 |
| 26 | MP0003705_abnormal_hypodermis_morpholog | 1.24892553 |
| 27 | MP0010368_abnormal_lymphatic_system | 1.24747281 |
| 28 | MP0003186_abnormal_redox_activity | 1.22395124 |
| 29 | MP0009643_abnormal_urine_homeostasis | 1.20256979 |
| 30 | MP0000598_abnormal_liver_morphology | 1.16502423 |
| 31 | MP0003656_abnormal_erythrocyte_physiolo | 1.15589195 |
| 32 | MP0009764_decreased_sensitivity_to | 1.09116456 |
| 33 | MP0002254_reproductive_system_inflammat | 1.03470253 |
| 34 | MP0009763_increased_sensitivity_to | 1.02220205 |
| 35 | MP0005670_abnormal_white_adipose | 1.01097963 |
| 36 | MP0005451_abnormal_body_composition | 0.97832832 |
| 37 | MP0000604_amyloidosis | 0.97243672 |
| 38 | MP0008469_abnormal_protein_level | 0.94246254 |
| 39 | MP0005636_abnormal_mineral_homeostasis | 0.90085903 |
| 40 | MP0002876_abnormal_thyroid_physiology | 0.86987184 |
| 41 | MP0009642_abnormal_blood_homeostasis | 0.85157403 |
| 42 | MP0005408_hypopigmentation | 0.84538855 |
| 43 | MP0004130_abnormal_muscle_cell | 0.83878637 |
| 44 | MP0002282_abnormal_trachea_morphology | 0.82264649 |
| 45 | MP0004381_abnormal_hair_follicle | 0.80569697 |
| 46 | MP0005220_abnormal_exocrine_pancreas | 0.79316107 |
| 47 | MP0005187_abnormal_penis_morphology | 0.78618840 |
| 48 | MP0005084_abnormal_gallbladder_morpholo | 0.78583579 |
| 49 | MP0005376_homeostasis/metabolism_phenot | 0.78035734 |
| 50 | MP0006036_abnormal_mitochondrial_physio | 0.76847495 |
| 51 | MP0001915_intracranial_hemorrhage | 0.76033002 |
| 52 | MP0004782_abnormal_surfactant_physiolog | 0.75960088 |
| 53 | MP0002078_abnormal_glucose_homeostasis | 0.75039757 |
| 54 | MP0005535_abnormal_body_temperature | 0.74306499 |
| 55 | MP0009765_abnormal_xenobiotic_induced | 0.73642464 |
| 56 | MP0005334_abnormal_fat_pad | 0.72767990 |
| 57 | MP0005330_cardiomyopathy | 0.72570975 |
| 58 | MP0002971_abnormal_brown_adipose | 0.72428133 |
| 59 | MP0003690_abnormal_glial_cell | 0.71692006 |
| 60 | MP0002332_abnormal_exercise_endurance | 0.65771395 |
| 61 | MP0003724_increased_susceptibility_to | 0.64857091 |
| 62 | MP0009384_cardiac_valve_regurgitation | 0.64467060 |
| 63 | MP0005266_abnormal_metabolism | 0.63858689 |
| 64 | MP0008872_abnormal_physiological_respon | 0.61927712 |
| 65 | MP0001661_extended_life_span | 0.60612101 |
| 66 | MP0009379_abnormal_foot_pigmentation | 0.60584309 |
| 67 | MP0005023_abnormal_wound_healing | 0.59208675 |
| 68 | MP0004215_abnormal_myocardial_fiber | 0.58211522 |
| 69 | MP0004084_abnormal_cardiac_muscle | 0.58076633 |
| 70 | MP0002249_abnormal_larynx_morphology | 0.57976185 |
| 71 | MP0000751_myopathy | 0.57930834 |
| 72 | MP0006138_congestive_heart_failure | 0.57270692 |
| 73 | MP0003879_abnormal_hair_cell | 0.57265149 |
| 74 | MP0000639_abnormal_adrenal_gland | 0.56105270 |
| 75 | MP0009053_abnormal_anal_canal | 0.54910052 |
| 76 | MP0000579_abnormal_nail_morphology | 0.54130673 |
| 77 | MP0001756_abnormal_urination | 0.53116546 |
| 78 | MP0000566_synostosis | 0.53035968 |
| 79 | MP0003329_amyloid_beta_deposits | 0.51992117 |
| 80 | MP0002928_abnormal_bile_duct | 0.51970788 |
| 81 | MP0006035_abnormal_mitochondrial_morpho | 0.51641616 |
| 82 | MP0001544_abnormal_cardiovascular_syste | 0.50652525 |
| 83 | MP0005385_cardiovascular_system_phenoty | 0.50652525 |
| 84 | MP0005448_abnormal_energy_balance | 0.50105574 |
| 85 | MP0005666_abnormal_adipose_tissue | 0.49810760 |
| 86 | MP0002796_impaired_skin_barrier | 0.47922402 |
| 87 | MP0003436_decreased_susceptibility_to | 0.47289143 |
| 88 | MP0005464_abnormal_platelet_physiology | 0.47116548 |
| 89 | MP0008775_abnormal_heart_ventricle | 0.46965493 |
| 90 | MP0004036_abnormal_muscle_relaxation | 0.46826624 |
| 91 | MP0009785_altered_susceptibility_to | 0.46437931 |
| 92 | MP0005395_other_phenotype | 0.44339653 |
| 93 | MP0003075_altered_response_to | 0.42320546 |
| 94 | MP0002136_abnormal_kidney_physiology | 0.41816336 |
| 95 | MP0003638_abnormal_response/metabolism_ | 0.41538129 |
| 96 | MP0003646_muscle_fatigue | 0.41408869 |
| 97 | MP0002837_dystrophic_cardiac_calcinosis | 0.40935931 |
| 98 | MP0008873_increased_physiological_sensi | 0.40535492 |
| 99 | MP0008874_decreased_physiological_sensi | 0.39481699 |
| 100 | MP0003718_maternal_effect | 0.39352146 |
| 101 | MP0005165_increased_susceptibility_to | 0.39223397 |
| 102 | MP0010630_abnormal_cardiac_muscle | 0.39188248 |
| 103 | MP0004510_myositis | 0.38913156 |
| 104 | MP0005164_abnormal_response_to | 0.38909713 |
| 105 | MP0005248_abnormal_Harderian_gland | 0.38677971 |
| 106 | MP0003953_abnormal_hormone_level | 0.37962182 |
| 107 | MP0002822_catalepsy | 0.37449187 |
| 108 | MP0009115_abnormal_fat_cell | 0.36648504 |
| 109 | MP0002132_abnormal_respiratory_system | 0.36504806 |
| 110 | MP0009780_abnormal_chondrocyte_physiolo | 0.36262070 |
| 111 | MP0005075_abnormal_melanosome_morpholog | 0.35581348 |
| 112 | MP0002972_abnormal_cardiac_muscle | 0.35541765 |
| 113 | MP0002128_abnormal_blood_circulation | 0.35520359 |
| 114 | MP0004484_altered_response_of | 0.35004672 |
| 115 | MP0001881_abnormal_mammary_gland | 0.34846400 |
| 116 | MP0000427_abnormal_hair_cycle | 0.33421339 |
| 117 | MP0000467_abnormal_esophagus_morphology | 0.33197078 |
| 118 | * MP0005166_decreased_susceptibility_to | 0.32900887 |
| 119 | MP0002269_muscular_atrophy | 0.32831638 |
| 120 | MP0002970_abnormal_white_adipose | 0.32436731 |
| 121 | MP0002060_abnormal_skin_morphology | 0.31991435 |
| 122 | MP0006082_CNS_inflammation | 0.31882039 |
| 123 | MP0009672_abnormal_birth_weight | 0.31609683 |
| 124 | MP0004883_abnormal_blood_vessel | 0.31065466 |
| 125 | MP0005058_abnormal_lysosome_morphology | 0.30843042 |
| 126 | MP0000249_abnormal_blood_vessel | 0.30579034 |
| 127 | MP0004087_abnormal_muscle_fiber | 0.30352518 |
| 128 | MP0000230_abnormal_systemic_arterial | 0.30341496 |
| 129 | MP0004264_abnormal_extraembryonic_tissu | 0.29440413 |
| 130 | MP0001845_abnormal_inflammatory_respons | 0.29285149 |
| 131 | MP0002295_abnormal_pulmonary_circulatio | 0.27950467 |
| 132 | MP0002168_other_aberrant_phenotype | 0.27822020 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.80193726 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.38822543 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.16861541 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.66741771 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.56998828 |
| 6 | * Complement deficiency (HP:0004431) | 6.44446711 |
| 7 | Xanthomatosis (HP:0000991) | 6.20476109 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 6.09332427 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.27187813 |
| 10 | Joint hemorrhage (HP:0005261) | 4.80843550 |
| 11 | Abnormality of the common coagulation pathway (HP:0010990) | 4.62823677 |
| 12 | Epidermoid cyst (HP:0200040) | 4.61016766 |
| 13 | * Abnormality of complement system (HP:0005339) | 4.60623494 |
| 14 | Hyperglycinemia (HP:0002154) | 4.59482786 |
| 15 | Hypolipoproteinemia (HP:0010981) | 4.57914564 |
| 16 | Hyperammonemia (HP:0001987) | 4.49242607 |
| 17 | Fat malabsorption (HP:0002630) | 4.48080142 |
| 18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.18990020 |
| 19 | Ketosis (HP:0001946) | 4.12287749 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.05046383 |
| 21 | Hypoalphalipoproteinemia (HP:0003233) | 4.00477354 |
| 22 | Abnormality of the intrinsic pathway (HP:0010989) | 3.98431229 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.94105816 |
| 24 | Abnormality of methionine metabolism (HP:0010901) | 3.92069784 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.88352825 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.88352825 |
| 27 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.86275102 |
| 28 | Hyperglycinuria (HP:0003108) | 3.85450651 |
| 29 | Conjugated hyperbilirubinemia (HP:0002908) | 3.83202743 |
| 30 | Hypoglycemic coma (HP:0001325) | 3.72385707 |
| 31 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.64623893 |
| 32 | Systemic lupus erythematosus (HP:0002725) | 3.59484002 |
| 33 | Steatorrhea (HP:0002570) | 3.52432072 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.36695246 |
| 35 | Hypercholesterolemia (HP:0003124) | 3.34003600 |
| 36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.24937830 |
| 37 | Hyperbilirubinemia (HP:0002904) | 3.15903833 |
| 38 | Hypochromic microcytic anemia (HP:0004840) | 3.15563413 |
| 39 | Myocardial infarction (HP:0001658) | 3.14867723 |
| 40 | Spontaneous abortion (HP:0005268) | 3.13558683 |
| 41 | Abnormality of serum amino acid levels (HP:0003112) | 3.05170987 |
| 42 | Hepatocellular carcinoma (HP:0001402) | 3.01832107 |
| 43 | Delayed CNS myelination (HP:0002188) | 2.98621857 |
| 44 | Abnormality of nucleobase metabolism (HP:0010932) | 2.98090537 |
| 45 | Skin nodule (HP:0200036) | 2.92274777 |
| 46 | Ketoacidosis (HP:0001993) | 2.89329844 |
| 47 | Neonatal hypoglycemia (HP:0001998) | 2.69127132 |
| 48 | Abnormality of purine metabolism (HP:0004352) | 2.64823859 |
| 49 | Metabolic acidosis (HP:0001942) | 2.64051195 |
| 50 | Gout (HP:0001997) | 2.61781995 |
| 51 | Osteomalacia (HP:0002749) | 2.53499534 |
| 52 | Neonatal onset (HP:0003623) | 2.49869114 |
| 53 | Lethargy (HP:0001254) | 2.49064811 |
| 54 | Mitral stenosis (HP:0001718) | 2.46870954 |
| 55 | Spastic diplegia (HP:0001264) | 2.46707703 |
| 56 | Purpura (HP:0000979) | 2.46018685 |
| 57 | Abnormal gallbladder morphology (HP:0012437) | 2.45022929 |
| 58 | Glomerulonephritis (HP:0000099) | 2.44623080 |
| 59 | Dicarboxylic aciduria (HP:0003215) | 2.43268440 |
| 60 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.43268440 |
| 61 | Cholelithiasis (HP:0001081) | 2.41519360 |
| 62 | Acanthocytosis (HP:0001927) | 2.41371931 |
| 63 | Atrioventricular block (HP:0001678) | 2.38699686 |
| 64 | Hypoglycemic seizures (HP:0002173) | 2.38085744 |
| 65 | Vascular calcification (HP:0004934) | 2.38043676 |
| 66 | Fair hair (HP:0002286) | 2.37001001 |
| 67 | Sensorimotor neuropathy (HP:0007141) | 2.35266126 |
| 68 | Cholecystitis (HP:0001082) | 2.33338109 |
| 69 | Abnormal gallbladder physiology (HP:0012438) | 2.33338109 |
| 70 | Pulmonary embolism (HP:0002204) | 2.29914369 |
| 71 | * Recurrent gram-negative bacterial infections (HP:0005420) | 2.28038202 |
| 72 | Amyloidosis (HP:0011034) | 2.27474884 |
| 73 | Cerebral edema (HP:0002181) | 2.25907773 |
| 74 | Irritability (HP:0000737) | 2.24351680 |
| 75 | Gingival bleeding (HP:0000225) | 2.20614683 |
| 76 | Esophageal varix (HP:0002040) | 2.19665206 |
| 77 | Pancreatitis (HP:0001733) | 2.19101123 |
| 78 | Malnutrition (HP:0004395) | 2.15620659 |
| 79 | Cardiovascular calcification (HP:0011915) | 2.11233154 |
| 80 | Thrombophlebitis (HP:0004418) | 2.10519676 |
| 81 | Hemorrhage of the eye (HP:0011885) | 2.09817148 |
| 82 | Enlarged kidneys (HP:0000105) | 2.08250377 |
| 83 | Brushfield spots (HP:0001088) | 2.07746662 |
| 84 | Reduced antithrombin III activity (HP:0001976) | 2.05667119 |
| 85 | Abnormality of the gallbladder (HP:0005264) | 2.04081236 |
| 86 | Late onset (HP:0003584) | 2.02138266 |
| 87 | Opisthotonus (HP:0002179) | 2.02026600 |
| 88 | Menorrhagia (HP:0000132) | 2.01232338 |
| 89 | Vomiting (HP:0002013) | 1.99774126 |
| 90 | Joint swelling (HP:0001386) | 1.93027347 |
| 91 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.92969727 |
| 92 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.92188720 |
| 93 | Abnormal cartilage morphology (HP:0002763) | 1.91651411 |
| 94 | Rickets (HP:0002748) | 1.90051285 |
| 95 | Generalized aminoaciduria (HP:0002909) | 1.86536538 |
| 96 | Abnormality of iron homeostasis (HP:0011031) | 1.86295551 |
| 97 | Hyperphosphaturia (HP:0003109) | 1.85088437 |
| 98 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85041901 |
| 99 | Abnormality of urine glucose concentration (HP:0011016) | 1.83622452 |
| 100 | Glycosuria (HP:0003076) | 1.83622452 |
| 101 | Heart block (HP:0012722) | 1.82936065 |
| 102 | Elevated hepatic transaminases (HP:0002910) | 1.82772924 |
| 103 | Renal cortical cysts (HP:0000803) | 1.82490672 |
| 104 | Poikilocytosis (HP:0004447) | 1.81379284 |
| 105 | Hyperglycemia (HP:0003074) | 1.80856656 |
| 106 | Increased serum ferritin (HP:0003281) | 1.80538690 |
| 107 | Nephritis (HP:0000123) | 1.77580341 |
| 108 | Status epilepticus (HP:0002133) | 1.77336105 |
| 109 | Hypophosphatemic rickets (HP:0004912) | 1.74604120 |
| 110 | Arthropathy (HP:0003040) | 1.73797301 |
| 111 | Elevated alkaline phosphatase (HP:0003155) | 1.73691800 |
| 112 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.73387657 |
| 113 | Abnormal atrioventricular conduction (HP:0005150) | 1.72723196 |
| 114 | Gangrene (HP:0100758) | 1.71637126 |
| 115 | Abnormality of vitamin metabolism (HP:0100508) | 1.70040900 |
| 116 | Increased serum pyruvate (HP:0003542) | 1.70029994 |
| 117 | Abnormality of proline metabolism (HP:0010907) | 1.67634587 |
| 118 | Hydroxyprolinuria (HP:0003080) | 1.67634587 |
| 119 | Bifid scrotum (HP:0000048) | 1.65235743 |
| 120 | Abnormal biliary tract physiology (HP:0012439) | 1.63875660 |
| 121 | Bile duct proliferation (HP:0001408) | 1.63875660 |
| 122 | Epistaxis (HP:0000421) | 1.63658589 |
| 123 | Generalized hypopigmentation of hair (HP:0011358) | 1.62697513 |
| 124 | Cerebral palsy (HP:0100021) | 1.60854640 |
| 125 | Blue irides (HP:0000635) | 1.58740466 |
| 126 | Abnormality of the Achilles tendon (HP:0005109) | 1.57306039 |
| 127 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.57141880 |
| 128 | Potter facies (HP:0002009) | 1.54264280 |
| 129 | Facial shape deformation (HP:0011334) | 1.54264280 |
| 130 | Increased mean platelet volume (HP:0011877) | 1.52908312 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.52193021 |
| 2 | ERN1 | 5.12008917 |
| 3 | FGFR4 | 4.70371634 |
| 4 | MYLK | 4.44468951 |
| 5 | SIK1 | 4.11467657 |
| 6 | ERBB4 | 3.85411818 |
| 7 | TAOK3 | 3.28041471 |
| 8 | INSRR | 2.74781522 |
| 9 | TTN | 2.36200273 |
| 10 | MAP2K4 | 2.24278148 |
| 11 | MAPK11 | 2.18873667 |
| 12 | MST1R | 2.13615547 |
| 13 | LATS1 | 1.88074077 |
| 14 | TYK2 | 1.82244542 |
| 15 | EPHA2 | 1.81606415 |
| 16 | TRIB3 | 1.78149883 |
| 17 | PIK3CG | 1.64800178 |
| 18 | FGFR2 | 1.58202409 |
| 19 | NEK9 | 1.58167837 |
| 20 | LMTK2 | 1.52517847 |
| 21 | FLT3 | 1.44625465 |
| 22 | PTK6 | 1.42667035 |
| 23 | NLK | 1.39879364 |
| 24 | ABL2 | 1.39364294 |
| 25 | PRPF4B | 1.38561934 |
| 26 | JAK2 | 1.35912462 |
| 27 | FRK | 1.34094518 |
| 28 | PKN2 | 1.33879794 |
| 29 | OBSCN | 1.31741433 |
| 30 | PDK2 | 1.31441628 |
| 31 | MAP3K2 | 1.29689628 |
| 32 | DAPK2 | 1.29262489 |
| 33 | ERBB2 | 1.28124861 |
| 34 | MAP3K7 | 1.27178771 |
| 35 | DMPK | 1.21660433 |
| 36 | JAK1 | 1.19210751 |
| 37 | MUSK | 1.18297261 |
| 38 | FER | 1.09876517 |
| 39 | KDR | 1.08732454 |
| 40 | TBK1 | 1.08032876 |
| 41 | MAPK15 | 1.07160866 |
| 42 | PRKAA2 | 1.07004810 |
| 43 | GRK6 | 1.02178682 |
| 44 | TRPM7 | 1.01817841 |
| 45 | MAP3K14 | 1.01586660 |
| 46 | MAP2K3 | 1.00165575 |
| 47 | MAPKAPK3 | 0.99931120 |
| 48 | EPHB1 | 0.99888472 |
| 49 | MAP3K10 | 0.99571569 |
| 50 | EPHA3 | 0.99178802 |
| 51 | TIE1 | 0.97812446 |
| 52 | IRAK3 | 0.97671561 |
| 53 | BLK | 0.94566020 |
| 54 | CDK6 | 0.93889292 |
| 55 | MAPK4 | 0.91598089 |
| 56 | MET | 0.91477732 |
| 57 | NTRK3 | 0.91460201 |
| 58 | STK38L | 0.89528564 |
| 59 | PRKD1 | 0.89445319 |
| 60 | PINK1 | 0.88985474 |
| 61 | PRKG1 | 0.88208445 |
| 62 | PRKCZ | 0.87564212 |
| 63 | PRKACA | 0.86778517 |
| 64 | CAMK1D | 0.86017414 |
| 65 | PKN1 | 0.83474777 |
| 66 | CAMK2G | 0.83265552 |
| 67 | TGFBR2 | 0.80712762 |
| 68 | MAP3K3 | 0.79804535 |
| 69 | FGFR3 | 0.77410693 |
| 70 | RIPK1 | 0.75835540 |
| 71 | MAPK12 | 0.74982250 |
| 72 | GSK3A | 0.73317771 |
| 73 | PRKACG | 0.71320769 |
| 74 | MAP3K11 | 0.66793441 |
| 75 | CSK | 0.64009789 |
| 76 | PRKAA1 | 0.63223082 |
| 77 | PRKCE | 0.59850630 |
| 78 | SGK3 | 0.58303784 |
| 79 | DYRK1B | 0.57213009 |
| 80 | TNK2 | 0.56989163 |
| 81 | CAMK2D | 0.56867309 |
| 82 | MAPK7 | 0.55485948 |
| 83 | CSF1R | 0.55106272 |
| 84 | RPS6KA3 | 0.54586724 |
| 85 | MAP2K6 | 0.53765333 |
| 86 | PRKACB | 0.53525784 |
| 87 | GRK7 | 0.52287621 |
| 88 | IKBKE | 0.51606423 |
| 89 | PTK2 | 0.51287880 |
| 90 | CAMKK2 | 0.49946870 |
| 91 | PDPK1 | 0.48974026 |
| 92 | EGFR | 0.48736889 |
| 93 | IGF1R | 0.47611646 |
| 94 | PRKCQ | 0.47395394 |
| 95 | GRK1 | 0.47155700 |
| 96 | STK38 | 0.47111641 |
| 97 | CDC42BPA | 0.46808619 |
| 98 | MAP2K1 | 0.44197303 |
| 99 | SGK1 | 0.44184885 |
| 100 | CAMK1G | 0.43781917 |
| 101 | SGK2 | 0.40654488 |
| 102 | CAMKK1 | 0.40509962 |
| 103 | CDK4 | 0.38943073 |
| 104 | ROCK1 | 0.38512129 |
| 105 | SRC | 0.38479530 |
| 106 | CSNK1G1 | 0.38467360 |
| 107 | AKT3 | 0.38452609 |
| 108 | KSR2 | 0.38294733 |
| 109 | ICK | 0.38050918 |
| 110 | PRKCB | 0.37415019 |
| 111 | AKT2 | 0.37159347 |
| 112 | BRSK2 | 0.36763627 |
| 113 | MAP3K5 | 0.36245561 |
| 114 | PRKCH | 0.36055112 |
| 115 | MAP3K13 | 0.35212242 |
| 116 | RET | 0.34705970 |
| 117 | MTOR | 0.34385718 |
| 118 | PRKCG | 0.34091900 |
| 119 | IRAK1 | 0.33573015 |
| 120 | LATS2 | 0.32925297 |
| 121 | BMX | 0.31566779 |
| 122 | PDGFRA | 0.31131039 |
| 123 | ABL1 | 0.30838342 |
| 124 | MAP3K6 | 0.29891634 |
| 125 | MAP3K1 | 0.29408661 |
| 126 | CAMK4 | 0.29048835 |
| 127 | ZAP70 | 0.25996072 |
| 128 | TAOK2 | 0.25964639 |
| 129 | SGK223 | 0.24740387 |
| 130 | SGK494 | 0.24740387 |
| 131 | STK3 | 0.24088760 |
| 132 | PDK1 | 0.23700702 |
| 133 | PRKCA | 0.23053517 |
| 134 | IRAK2 | 0.21964215 |
| 135 | PIK3CA | 0.21758815 |
| 136 | EPHA4 | 0.21491232 |
| 137 | PAK3 | 0.20425647 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 5.03582832 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.44911957 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.35836143 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.13478969 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.04334357 |
| 6 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.97534523 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.78572672 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.64715472 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.55815812 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.50212191 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.40973506 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.40708383 |
| 13 | Peroxisome_Homo sapiens_hsa04146 | 2.13758395 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.11257734 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.09913021 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.03641233 |
| 17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.92820884 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.90669711 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.88712849 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.88226394 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.85451165 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.85312421 |
| 23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.82688708 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.80848878 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.76588331 |
| 26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.69589238 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.67993399 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.67987916 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.67291548 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.60889255 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.57314157 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.55870420 |
| 33 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.52920100 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.51039827 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.48293315 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.46040876 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.43430392 |
| 38 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.36391067 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.30984882 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.30340755 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.29125059 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26853992 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.26424376 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.22747911 |
| 45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.20856112 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.14419451 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.14122347 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.12071367 |
| 49 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.09663742 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.08961498 |
| 51 | Carbon metabolism_Homo sapiens_hsa01200 | 1.08001432 |
| 52 | Sulfur relay system_Homo sapiens_hsa04122 | 0.96455126 |
| 53 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.94108240 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.89880508 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.87339273 |
| 56 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.86978246 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.78617558 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.78171671 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.78076687 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.72881850 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66588552 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.65433948 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64760030 |
| 64 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.59341096 |
| 65 | * Prion diseases_Homo sapiens_hsa05020 | 0.54810307 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.52830306 |
| 67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44101929 |
| 68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.42578504 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42272932 |
| 70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.26247218 |
| 71 | Insulin resistance_Homo sapiens_hsa04931 | 0.25411550 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22842662 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.22750568 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.19787320 |
| 75 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17344767 |
| 76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.17244610 |
| 77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.11303491 |
| 78 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10412082 |
| 79 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03856868 |
| 80 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.02759272 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2187519 |
| 82 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2156397 |
| 83 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2144483 |
| 84 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.2071615 |
| 85 | Pertussis_Homo sapiens_hsa05133 | -0.2027610 |
| 86 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.2012997 |
| 87 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1949621 |
| 88 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1892554 |
| 89 | Bladder cancer_Homo sapiens_hsa05219 | -0.1879668 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1688608 |
| 91 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1529277 |
| 92 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1343072 |
| 93 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1334513 |
| 94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1266119 |
| 95 | Hepatitis C_Homo sapiens_hsa05160 | -0.1254380 |
| 96 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.1245622 |
| 97 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | -0.1179963 |
| 98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1138808 |
| 99 | * Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1131761 |
| 100 | Amoebiasis_Homo sapiens_hsa05146 | -0.1101916 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1084102 |
| 102 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | -0.1052225 |
| 103 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1038421 |
| 104 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0928022 |
| 105 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0820355 |
| 106 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0729809 |
| 107 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0665705 |
| 108 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0624646 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0623419 |
| 110 | Mineral absorption_Homo sapiens_hsa04978 | -0.0177820 |

